March 29, 2010
Soladek is marketed with claims that the product treats “hypo and avitaminosis, rickets, growth, dentition, lactation, fractures, infection, convalescence, protection and regeneration of certain epithelium (bronchial, glandular, ocular, cutaneous), corticotherapy, aging and pregnancy.” The product is sold in a box labeled in Spanish and containing a vial of the solution.
The FDA recently received information that tested samples of Soladek contained levels of vitamin A and vitamin D that were many times the recommended daily allowances for these vitamins. Intake of excessively high levels of these vitamins poses a risk to human health.
The FDA also received seven reports of serious health problems occurring in consumers using the product. The problems include decreased renal function, elevated levels of calcium in the blood, fatigue, heart arrhythmia, vomiting and diarrhea.
Retailers advising any consumers who have been experiencing any of the above symptoms and have been using Soladek should instruct them to see a doctor immediately, and caution consumers in possession of Soladek to stop using the product immediately.
Soladek cannot currently be marketed legally in the United States because U.S. law prohibits the sale of products claiming to treat disease conditions without review and approval by the FDA. However, the reports of adverse events and other information leads the FDA to conclude that Soladek may be available illegally in the country; therefore, the agency is issuing this warning.
For more information, visit www.fda.gov.
“Topricin has proven to be effective in resolving pain issues for individuals suffering from neuropathy, with many reporting that it has helped to reduce or eliminate their dependency on oral pain medications,” said Lou Paradise, president of Topical BioMedics and product formulator. “This is a ground-breaking advancement, as the medical community has struggled for years to find viable treatment options for patients with nerve-related pain. With no other options at hand, they have had to rely on the pharmaceutical community, whose chemical-based drugs prove ineffective and compromise the health of the patient by causing more harm then good due to the serious side effects they pose. Chemical compounds/drugs attempt to treat the symptoms and not the cause of the problem, and as a result cannot provide the relief that people suffering with neuropathic pain seek.”
For more information, visit www.topricin.com.
For more information, visit www.hemphistoryweek.com.
Visitors may pick their own organic tulips for $1-2 a stem from EcoTulips’ 10,000-square-foot organic garden while tiptoeing among 20 varieties of more than 60,000 tulips. They are also welcome to stroll through the beautiful inspiration garden (full of organic tulips as well as organic daffodils, crocuses and grape hyacinths), have a picnic, and enjoy wine and organic foods from local vendors.For more information, visit www.ecotulips.com.
Terry Lemerond, founder and president of EuroPharma, Inc. (Green Bay, WI) and owner of the natural food store Terry Naturally, said he has seen surging sales of iodine supplements since the Japanese disasters. “Iodine is in great demand because of people’s fear of radioactive contamination.”
Natural Grocers in Longmont, CO, sold out of all its kelp and much of its green foods supplements. Similarly, a Whole Foods Market in California’s Bay Area reported selling out of its kelp supplements.
This comes despite the U.S. Environmental Protection Agency’s (EPA) announcement that its RadNet system has not detected any radiation levels of concern. The U.S. Department of Energy, which has radiation monitoring equipment at research facilities around the country, has also not detected any radiation levels of concern.
However, “anti-radiation” supplement sales have not gone unnoticed by government officials. The U.S. Food and Drug Administration (FDA) warned consumers to be wary of supplements and other products sold online and in retail stores that claim to treat or prevent the effects of radiation but are not FDA-approved for that purpose.
The FDA didn’t specify which products might be making false claims. “These fraudulent products come in all varieties and could include dietary supplements, food items or products purporting to be drugs, devices or vaccines,” the FDA said.
In a message issued to Natural Product Association (NPA) members regarding the demand for potassium iodide, John Gay, executive director and CEO, stated, “Health officials have raised concerns about consumers taking improper dosages of potassium iodide. They recommend consultation with a health professional before taking potassium iodide at levels higher than the RDA.”
Natural product suppliers and manufacturers with ties to Japan have issued statements regarding the disasters. Wakunaga of America, which farms garlic and other materials to manufacture herbal supplements in particular, has a new 53,000-square-foot facility in Mira Loma, CA as well as operations in Tokyo and Hiroshima, Japan. When asked if the earthquake and tsunami have affected the company, the company’s spokesman Albert Dahbour said, “So far no ... but transportation across Japan is in a bad situation. This may disrupt supply/distribution, employee transportation, etc. Also, phone lines were down ... so it’s hard to get all the info.”
Fuji Health Science, Inc. (Burlington, NJ) assured its customers in all industries that the production facilities of its parent company, Fuji Chemical Industry Co., Ltd. of Japan were not in danger and did not sustain any damage due to the catastrophe. Fuji’s headquarters and production facilities are located in Toyama Prefecture, which is in a different area of Japan on the western side of the central mountain range unaffected by the current quake and resulting disaster.
To affirm ConcenTrace’s GRAS status, TMR sought out an expert panel from AIBMR Life Sciences Inc. (Puyallup, WA) because of its experience, knowledge and expertise with GRAS self-affirmations. The expert panel included physicians and two PhD toxicologists with 83 years combined experience in toxicology, who also worked as division heads for the Food and Drug Administration (FDA).
“Achieving GRAS status for ConcenTrace is major step for our company,” said Scott Perkes, managing partner of TMR. “Now that ConcenTrace is GRAS, not only can current and potential consumers of ConcenTrace be even more confident in its safety as a dietary supplement, but food and beverage companies who are looking to fortify their products with a water-soluble complex of over 72 ionic trace minerals can now do so with that same confidence.”
For more information, visit www.traceminerals.com.